Our vision: individualize cancer medicine
We offer multiple services in our holding structure
As holding, BioNTech SE encompasses several subsidiaries focused on specific aspects of the BioNTech business. These includes our therapeutic development units as well as certain subsidiaries that also provide external service offerings
- JPT Peptide Technologies GmbH
Our fully-owned subsidiary in Berlin provides peptide manufacturing services.
For more information please visit the JPT website or contact firstname.lastname@example.org.
- BioNTech Innovative Manufacturing Service GmbH (IMFS)
BioNTech Innovative Manufacturing Service GmbH (BIMFS) is a fully-owned manufacturing subsidiary in Idar-Oberstein that offers leading GMP manufacturing services for mRNA and cell and gene therapies.
For more information please visit the IMFS website or contact email@example.com.
- BioNTech Small Molecules GmbH
BioNTech Small Molecules GmbH offers fully-integrated research services, covering all scientific disciplines for small molecule drug discovery: from hit identification via in silico screening through hit-to-lead and lead optimization to preclinical development.
For more information, please contact firstname.lastname@example.org.
- BioNTech Diagnostics GmbH
BioNTech Diagnostics GmbH develops and manufactures biomarker-based in vitro diagnostic devices (IVDD) and commercializes products through selected partners. The first commercial diagnostic was launched in 2015.
More information on MammaTyper can be found here.
BioNTech RNA Pharmaceuticals GmbH
BioNTech Cell & Gene Therapies GmbH
BioNTech Protein Therapeutics GmbH
BioNTech Small Molecules GmbH
BioNTech Research & Development, Inc.